BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 37989651)

  • 1. Translational research for the development of treatment of patients with neurogenetic diseases: An important step for Angelman syndrome.
    Dan B
    Eur J Paediatr Neurol; 2023 Nov; 47():A2. PubMed ID: 37989651
    [No Abstract]   [Full Text] [Related]  

  • 2. Sleep Disorders in Childhood Neurogenetic Disorders.
    Dosier LBM; Vaughn BV; Fan Z
    Children (Basel); 2017 Sep; 4(9):. PubMed ID: 28895939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neurogenetic dialogue illustrated by the "pantin hilare" of angelman syndrome].
    Dan B
    Bull Mem Acad R Med Belg; 2010; 165(7-9):327-33; discussion 334-7. PubMed ID: 21513093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Road to Personalized Therapies: Lessons Learned From Angelman Syndrome.
    Duis J
    Am J Intellect Dev Disabil; 2022 Mar; 127(2):95-98. PubMed ID: 35180775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurogenetic disorders and treatment of associated seizures.
    Faulkner MA; Singh SP
    Pharmacotherapy; 2013 Mar; 33(3):330-43. PubMed ID: 23400943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulant intolerance in children with Angelman syndrome with hyperactivity: a case series.
    Keary CJ; Thom RP; McDougle CJ
    Psychiatr Genet; 2022 Apr; 32(2):80-86. PubMed ID: 35348128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angelman syndrome - insights into a rare neurogenetic disorder.
    Buiting K; Williams C; Horsthemke B
    Nat Rev Neurol; 2016 Oct; 12(10):584-93. PubMed ID: 27615419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurologic manifestations of Angelman syndrome.
    Thibert RL; Larson AM; Hsieh DT; Raby AR; Thiele EA
    Pediatr Neurol; 2013 Apr; 48(4):271-9. PubMed ID: 23498559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinctive pattern of behavioral functioning in Angelman syndrome.
    Summers JA; Feldman MA
    Am J Ment Retard; 1999 Jul; 104(4):376-84. PubMed ID: 10450464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An ASO therapy for Angelman syndrome that targets an evolutionarily conserved region at the start of the
    Dindot SV; Christian S; Murphy WJ; Berent A; Panagoulias J; Schlafer A; Ballard J; Radeva K; Robinson R; Myers L; Jepp T; Shaheen H; Hillman P; Konganti K; Hillhouse A; Bredemeyer KR; Black L; Douville J; ;
    Sci Transl Med; 2023 Mar; 15(688):eabf4077. PubMed ID: 36947593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neuropsychiatric phenotype of Angelman syndrome and clinical care: report of seven cases].
    Cote-Orozco JE; Mera-Solarte PD; Espinosa-García E
    Arch Argent Pediatr; 2017 Apr; 115(2):e99-e103. PubMed ID: 28318193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Excessive Laughter-like Vocalizations, Microcephaly, and Translational Outcomes in the
    Berg EL; Jami SA; Petkova SP; Berz A; Fenton TA; Lerch JP; Segal DJ; Gray JA; Ellegood J; Wöhr M; Silverman JL
    J Neurosci; 2021 Oct; 41(42):8801-8814. PubMed ID: 34475199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations in white matter pathways in Angelman syndrome.
    Peters SU; Kaufmann WE; Bacino CA; Anderson AW; Adapa P; Chu Z; Yallampalli R; Traipe E; Hunter JV; Wilde EA
    Dev Med Child Neurol; 2011 Apr; 53(4):361-7. PubMed ID: 21121904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dental treatment in Angelman syndrome patients. 8 case reports.
    Gallo C; Marcato A; Beghetto M; Stellini E
    Eur J Paediatr Dent; 2012 Dec; 13(4):345-8. PubMed ID: 23270298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angelman syndrome and thyroid dysfunction.
    Monterrubio-Ledezma CE; Bobadilla-Morales L; Pimentel-Gutiérrez HJ; Corona-Rivera JR; Corona-Rivera A
    Genet Couns; 2012; 23(3):353-7. PubMed ID: 23072182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sleep phenotypes in infants and toddlers with neurogenetic syndromes.
    Abel EA; Tonnsen BL
    Sleep Med; 2017 Oct; 38():130-134. PubMed ID: 29031747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of environmental events on smiling and laughing behavior in Angelman syndrome.
    Oliver C; Demetriades L; Hall S
    Am J Ment Retard; 2002 May; 107(3):194-200. PubMed ID: 11966332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early detection of Angelman syndrome resulting from de novo paternal isodisomic 15q UPD and review of comparable cases.
    Horváth E; Horváth Z; Isaszegi D; Gergev G; Nagy N; Szabó J; Sztriha L; Széll M; Endreffy E
    Mol Cytogenet; 2013 Sep; 6(1):35. PubMed ID: 24011290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using generalizability theory to evaluate the comparative reliability of developmental measures in neurogenetic syndrome and low-risk populations.
    Hamrick LR; Haney AM; Kelleher BL; Lane SP
    J Neurodev Disord; 2020 Jun; 12(1):16. PubMed ID: 32503425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Angelman syndrome: clinical and genetic model].
    Dan B; Chéron G
    Rev Neurol (Paris); 2003 May; 159(5 Pt 1):499-510. PubMed ID: 12773895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.